APA (7th ed.) Citation

Ataka, T., Kimura, N., Kaneko, N., Masuda, T., Takeuchi, Y., Yabuuchi, K., . . . Matsubara, E. (2024, October). Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment. Alzheimer’s & Dementia: Translational Research & Clinical Interventions.

Chicago Style (17th ed.) Citation

Ataka, Takuya, et al. "Plasma Amyloid Beta Biomarkers Predict Amyloid Positivity and Longitudinal Clinical Progression in Mild Cognitive Impairment." Alzheimer’s & Dementia: Translational Research & Clinical Interventions Oct. 2024.

MLA (9th ed.) Citation

Ataka, Takuya, et al. "Plasma Amyloid Beta Biomarkers Predict Amyloid Positivity and Longitudinal Clinical Progression in Mild Cognitive Impairment." Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Oct. 2024.